carvedilol and thromboplastin

carvedilol has been researched along with thromboplastin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harada, N; Katsuya, H; Komura, H; Mizuochi, Y; Molor-Erdene, P; Okajima, K; Tsuda, T; Uchiba, M	1
Du, Y; Ge, Z; Liu, W; Yu, J; Zhao, J	1

Other Studies

2 other study(ies) available for carvedilol and thromboplastin

Article	Year
Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. Translational research : the journal of laboratory and clinical medicine, 2007, Volume: 149, Issue:4 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Early Growth Response Protein 1; Extracellular Signal-Regulated MAP Kinases; Humans; Lipopolysaccharides; Monocytes; NF-kappa B; Phosphorylation; Propanolamines; Thromboplastin; Transcription Factor AP-1; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factors	2007
Combined effects of irbesartan and carvedilol on expression of tissue factor and tissue factor pathway inhibitor in rats after myocardial infarction. Heart and vessels, 2011, Volume: 26, Issue:6 Topics: Adrenergic Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Coagulation; Blotting, Western; Carbazoles; Carvedilol; Disease Models, Animal; Down-Regulation; Drug Therapy, Combination; Irbesartan; Lipoproteins; Male; Myocardial Infarction; Myocardium; Propanolamines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Thromboplastin	2011

Article

Year

Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro.

Translational research : the journal of laboratory and clinical medicine, 2007, Volume: 149, Issue:4

Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Early Growth Response Protein 1; Extracellular Signal-Regulated MAP Kinases; Humans; Lipopolysaccharides; Monocytes; NF-kappa B; Phosphorylation; Propanolamines; Thromboplastin; Transcription Factor AP-1; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factors

2007

Combined effects of irbesartan and carvedilol on expression of tissue factor and tissue factor pathway inhibitor in rats after myocardial infarction.

Heart and vessels, 2011, Volume: 26, Issue:6

Topics: Adrenergic Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Coagulation; Blotting, Western; Carbazoles; Carvedilol; Disease Models, Animal; Down-Regulation; Drug Therapy, Combination; Irbesartan; Lipoproteins; Male; Myocardial Infarction; Myocardium; Propanolamines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Thromboplastin

2011